Human Cytotrophoblast Expression of the von Hippel–Lindau Protein Is Downregulated during Uterine Invasion in Situ and Upregulated by Hypoxia in Vitro  by Genbacev, Olga et al.
oc
c
s
d
s
u
w
p
i
t
Developmental Biology 233, 526–536 (2001)
doi:10.1006/dbio.2001.0231, available online at http://www.idealibrary.com onHuman Cytotrophoblast Expression of the von
Hippel–Lindau Protein Is Downregulated during
Uterine Invasion in Situ and Upregulated by
Hypoxia in Vitro
Olga Genbacev,* Ana Krtolica,† William Kaelin,‡ and
Susan J. Fisher*,§,¶,i ,1
*Department of Stomatology, §Department of Obstetrics, Gynecology, and Reproductive
Sciences, ¶Department of Pharmaceutical Chemistry, and iDepartment of Anatomy, University
f California–San Francisco, San Francisco, California 94143-0512; †Department of Cell and
Molecular Biology, Lawrence Berkeley National Laboratory, Berkeley, California 94720; and
‡Howard Hughes Medical Institute, Dana–Farber Cancer Institute and Harvard Medical
School, Boston, Massachusetts 02115
The von Hippel–Lindau tumor-suppressor protein (pVHL) regulates the stability of HIF1a and HIF2a and thus is pivotal in
ellular responses to changes in oxygen tension. Paradoxically, human cytotrophoblasts proliferate under hypoxic
onditions comparable to those measured in the early gestation placenta (2% O2), but differentiate into tumorlike invasive
cells under well-oxygenated conditions such as those found in the uterus. We sought to explain this phenomenon in terms
of pVHL expression. In situ, pVHL immunolocalized to villous cytotrophoblast stem cells, and expression was enhanced at
ites of cell column initiation; in both of these relatively hypoxic locations, cytoplasmic staining for HIF2a was also
etected. As cytotrophoblasts attached to and invaded the uterus, which results in their increased exposure to oxygen, pVHL
taining was abruptly downregulated concordant with localization of HIF2a to the nucleus. In vitro, hypoxia (2% O2)
pregulated cytotrophoblast pVHL expression together with HIF2a, which localized to the cytoplasm; culture under
ell-oxygenated conditions greatly reduced levels of both molecules. These results, together with the placental defects
reviously observed in VHL2/2 mice, suggest that pVHL is a component of the mechanism that transduces local differences
n oxygen tension at the maternal–fetal interface to changes in the biological behavior of cytotrophoblasts. Furthermore,
hese data provide the first example of oxygen-dependent changes in pVHL abundance. © 2001 Academic Press
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The placenta forms the structural and functional inter-
face between the mother and the embryo/fetus (reviewed by
Cross et al., 1994, Danisky and Fisher, 1998). The histolog-
ical features of this interface in humans are diagrammed in
Fig. 1. Initially (Fig. 1a), specialized placental cells termed
cytotrophoblasts emanate from anchoring villi and invade
1 To whom correspondence and reprint requests should be ad-
dressed at University of California San Francisco, Department of
Stomatology, Division of Oral Biology, HSW 604, 513 Parnassusv
Ave., San Francisco, CA 94143-0512. Fax: (415) 502-7338. E-mail:
sfisher@cgl.ucsf.edu.
526he uterine wall (interstitial invasion). As development
roceeds (Fig. 1b), these cells also breach the uterine veins
nd arteries they encounter (endovascular invasion). Their
nteractions with veins are confined to the portions of the
essels that lie near the inner surface of the uterus, but
ytotrophoblasts migrate in a retrograde direction along
uch of the intrauterine course of the arterioles. Eventu-
lly, these fetal cells completely replace the maternal
ndothelial lining and partially replace the muscular wall.
y 10–12 weeks of gestation, uterine arterial blood begins
o flow to the intervillous space, which is lined by the
ultinucleate syncytiotrophoblasts that cover the floatingilli and the cytotrophoblasts at the uterine surface. At a
0012-1606/01 $35.00
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t
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cFIG. 1. Schematic relating maturational changes in the anatomy of the maternal–fetal interface to alterations in the oxygen environment in
which placental development takes place. (a) Anchoring chorionic villi (AV) have specialized structures, termed cell columns (CC), that bridge
the gap between the maternal and fetal compartments. Villous cytotrophoblast stem cells (vCTB) enter the columns, where they differentiate.
The differentiated cells that emerge from the columns invade the uterus, thereby anchoring the placenta to the uterine wall. During much of the
first trimester of pregnancy (i.e., #10–12 weeks of gestation) invasion is confined to the uterine parenchyma (interstitial invasion). In the absence
f normal blood flow through the intervillous space, a steep oxygen gradient (depicted by the shaded triangle above a) is set up between the
lacenta, which is relatively hypoxic, and the uterus. (b) Sometime near the end of the first trimester (;10–12 weeks of pregnancy), a
ubpopulation of cytotrophoblasts also invades the resident uterine arteries and veins (endovascular invasion). This process diverts arterial blood
o the intervillous space, where the floating villi, covered with multinucleate syncytiotrophoblasts (STBs), reside. As a result there is a reduction
n the magnitude of the oxygen gradient between the placenta and the uterus (depicted by the shaded triangle above b). VC, mesenchymal villous
ores; cCTB, column cytotrophoblasts; iCTB, invasive cytotrophoblasts.
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528 Genbacev et al.functional level, nutrient, gas, and waste exchange take
place in the intervillous space. All the trophoblast popula-
tions are involved in integrating maternal and fetal physi-
ology, immunology, and endocrinology.
Placental structure and function are established during
cytotrophoblast differentiation along one of two pathways:
fusion (to form syncytium) or uterine invasion. Cytotropho-
blasts that invade the uterus acquire many unusual proper-
ties. As in tumor progression, their invasive characteristics
are enhanced by molecular mechanisms that include pro-
duction and activation of metalloproteinases, principally
MMP-9 (Librach et al., 1991). Once cytotrophoblasts com-
mit to differentiation along the invasive pathway, their
adhesion receptor phenotype is exquisitely modulated in a
stepwise fashion, another factor that enhances their inva-
siveness (Damsky and Fisher, 1998). Particularly striking is
the reduced staining for adhesion receptors characteristic of
polarized cytotrophoblast epithelial stem cells, integrin
a6b4 and E-cadherin, and the onset of expression of adhe-
ion receptors characteristic of endothelium: VE (vascular)-
adherin, IgG-family receptors vascular cell adhesion mol-
cule and platelet–endothelial cell adhesion molecule, and
ntegrins aVb3 and a1b1. Accordingly, this process is
ermed pseudovasculogenesis. As the cells modulate their
dhesion molecule expression, they also upregulate synthe-
is of a complex pericellular matrix that includes many
bronectin isoforms. The upstream regulatory factors that
ontrol these changes in proteinase and adhesion molecule
henotype include a variety of growth factors. In this
egard, vascular endothelial growth factor family members,
hich are expressed at the maternal–fetal interface, are
ttractive candidates for regulating pseudovasculogenesis
Clark et al., 1998). Other factors, such as hepatocyte
rowth factor/scatter factor, can promote invasion by inter-
cting with c-Met expressed on invading cytotrophoblasts
Nasu et al., 2000).
Our recent work shows that oxygen tension is also an
mportant regulator of cytotrophoblast differentiation/
nvasion. In this regard it is interesting to consider that the
lacenta is the first organ to function during development.
his hierarchy imposes novel requirements on cytotropho-
last growth and differentiation. For example, the critical
arly stages of placental development occur before the
onceptus accesses a supply of maternal blood (#10 weeks
f gestation; Fig. 1a) (Burton et al., 1999). In accord with this
onstraint, our previous work showed that cytotrophoblasts
roliferate in vitro under hypoxic conditions that are com-
arable to those found during early pregnancy in the uterine
umen and the superficial decidua. As trophoblast invasion
f the uterus proceeds, the placental cells encounter in-
reasingly higher oxygen levels (Fig. 1a), which trigger their
xit from the cell cycle and subsequent differentiation
Genbacev et al., 1996, 1997). Hypoxia also regulates cell
ate in the murine placenta (Adelman et al., 2000).
The paradoxical effects of oxygen in controlling the
alance between cytotrophoblast proliferation and differen- e
Copyright © 2001 by Academic Press. All rightiation prompted us to look for a molecular explanation.
iven that VHL2/2 mice die at embryonic day 8.5 as a result
f failures in placental development (Gnarra et al., 1997),
the von Hippel–Lindau protein (pVHL), which plays a key
role in cellular responses to changes in oxygen tension
(Maher and Kaelin, 1997; Zbar et al., 1999), was a logical
candidate. Germ-line mutation of the VHL gene in humans
gives rise to a hereditary cancer syndrome characterized by
development of vascular tumors of the retina and central
nervous system, in addition to renal carcinomas and pheo-
chromocytomas (Melmon and Rosen, 1964). Tumor devel-
opment in this setting is attributed to somatic inactivation
of the remaining wild-type VHL allele (Linehan et al., 1995).
The mechanisms by which pVHL expression suppresses
umor formation are not clear, but many of its known
unctions offer possible explanations. pVHL shuttles back
nd forth between the nucleus and the cytoplasm (Lee et al.,
999), forming multimeric complexes that are required for
biquitination (Lonergan et al., 1998; Stebbins et al., 1999),
nd hence degradation, of the hypoxia-inducible factor
HIF)1a and HIF2a transcription factors in the presence of
xygen (Cockman et al., 2000; Maxwell et al., 1999; Ohh et
al., 2000). Accordingly, cells lacking wild-type pVHL pro-
duce high levels of HIFs under well-oxygenated conditions
and consequently overexpress hypoxia-inducible genes.
Among these genes are those encoding angiogenic factors
(Hanahan and Folkman, 1996) and proteins involved in
glucose uptake and metabolism (Kaelin, 1999). pVHL also
plays a role in regulating the composition of the extracel-
lular matrix. It positively regulates fibronectin matrix as-
sembly (Ohh et al., 1998) and the production of tissue
inhibitors of metalloproteinases, and negatively regulates
the production of matrix metalloproteinases and hepato-
cyte growth factor/scatter factor-induced branching mor-
phogenesis (Koochekpour et al., 1999). Whether these latter
effects are related to the targeted destruction of HIFs is
unknown. Finally, pVHL has been implicated in the ability
of cells to exit the cycle in response to serum starvation in
vitro (Pause et al., 1998).
Here we describe the results of experiments in which we
studied pVHL expression as a function of cytotrophoblast
differentiation both in situ and in vitro. Our previous work
showed that the expression of many stage-specific antigens
that play an important role in placental development is
extensively modulated during the differentiation process
that gives rise to invasive cytotrophoblasts. pVHL fits into
this paradigm: the highest levels were found in cytotropho-
blast stem cells within the hypoxic placental compartment,
whereas staining diminished to undetectable levels as the
cells invaded the uterus and encountered oxygen. In accord
with their many vascular-like characteristics, differentiat-
ing cytotrophoblasts also modulated expression of the ma-
jor endothelial HIF, HIF2a, rather than the more widely
xpressed HIF1a. Since our previous work showed that
everal important aspects of cytotrophoblast differentiation
re regulated by changes in oxygen tension, we studied the
ffects of hypoxia on cytotrophoblast pVHL and HIF expres-
s of reproduction in any form reserved.
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529VHL Expression in Human Cytotrophoblastssion in vitro. As expected, we found increases in HIF2a, but
nexpectedly the abundance of pVHL also increased. To-
ether, these results offer insights into how placental de-
elopment is coupled to oxygen tension. These findings
lso raise the interesting possibility that pVHL expression
n other cells may be regulated by oxygen tension.
MATERIALS AND METHODS
Collection of Placentas
Chorionic villi with attached decidua were collected immedi-
ately after elective pregnancy terminations. Samples for immuno-
localization were collected directly into fixative. Samples for cell
isolation were stored briefly in ice-cold PBS. All samples were
obtained using procedures and guidelines approved by the Univer-
sity of California San Francisco Committee on Human Research.
Immunolocalization (Tissue Sections)
Placental tissues were fixed, sectioned, and processed for double
indirect immunolocalization as described previously (Damsky et
al., 1992; Zhou et al., 1993). Because of their relatively small size,
the entire maternal–fetal interface of eight individual first-
trimester placentas (6–8 weeks of gestation) was analyzed. Three
to five randomly chosen sites were biopsies from the same region of
six individual second-trimester placentas (16–18 weeks of gesta-
tion). All sections were stained with anti-cytokeratin antibody
(7D3; rat IgG), which specifically reacts with trophoblasts (Damsky
et al., 1992; Zhou et al., 1993), and one of the monoclonal
antibodies listed below. Anti-HIF1a monoclonal antibody was
purchased from Novus (Littleton, CO). A monoclonal antibody
that specifically recognizes HIF2a was the kind gift of Dr. Peter
Radcliffe (Oxford University). Anti-fibronectin was purchased from
Sigma Chemical Company (St. Louis, MO). Anti-pVHL (Ig32;
Pharmingen, San Diego, CA) was generated using a recombinant
fusion protein containing amino acids 1–213 of human VHL as the
immunogen (Kibel et al., 1995).
Tissue Culture
Anchoring villi were prepared for culture from 10 individual
first-trimester placentas as previously described (Genbacev et al.,
992; Genbacev and Miller, 1993). Briefly, small fragments of
lacental tissue from the maternal–fetal interface were teased apart
ntil they had the characteristic treelike appearance of chorionic
illi when they were viewed in a stereo microscope. Anchoring villi
ere identified by the attached remnants of cell columns. Light
icroscopic examination of hematoxylin-stained sections of villus
issue preparations consistently showed the presence of floating
nd anchoring villi and the absence of endometrial contamination.
Anchoring villi (wet weight, 5–10 mg) were cultured on the
urface of Matrigel-coated (Collaborative Research, Bedford, MA)
2-mm Millicell-CM culture dish inserts (0.4 mm; Millipore Corp.,
Bedford, MA). The inserts were then placed into 24-well dishes and
cultured up to 3 days in a mixture of F12 HAM/DMEM (1:1/v:v)
culture medium (Sigma Chemical Co.) supplemented with 0.1% of
an antibiotic/antimycotic preparation (500 units penicillin, 1 mg
streptomycin, 1.25 mg amphotericin B/ml; Sigma A-7295; Sigma
hemical Co.) and 10% fetal calf serum.
Control (n 5 5/experiment) and hypoxic cultures (n 5
Copyright © 2001 by Academic Press. All right/experiment) of explanted anchoring villi were maintained as
reviously described (Genbacev et al., 1997). Dissolved O2 at the
cell–medium interface, measured using a micro-oxygen electrode
(MI-730; Microelectrode Inc., Bedford, NH), was 20% under stan-
dard tissue culture conditions. Atmospheres of 10 and 2% O2 were
reated in a Bactron anaerobic incubator (Sheldon Manufacturing
nc., Cornelius, OR).
Immunolocalization (Explants)
Villi on filter inserts were washed with PBS, fixed for 1 h (4°C) in
4% paraformaldehyde, and washed again in PBS. For cultures
maintained in 2 and 10% O2, this procedure was performed in the
uter glove box, which was held at the same pO2 as the incubator.
Then the villi together with the Matrigel substrate were dissected
from the filter inserts, embedded in optimal cutting temperature
medium, and frozen in liquid nitrogen. Sections (5 mm) cut from
these blocks were stained with the same set of antibodies that was
used to analyze tissue sections (see above).
Immunoblotting (Explants)
Villus explants were cultured as described above from three
individual placentas. To quantify antigen expression, only cell
columns were analyzed, thereby eliminating signal from the rest of
the villus. Briefly, after 48 h, columns were identified by viewing
the filter inserts under a dissecting microscope. They were ampu-
tated from the villus at the site of initiation and solubilized in lysis
buffer at 0°C according to published methods (Almeida et al.,
2000). For cultures maintained in 2 and 10% O2, this procedure was
performed in the outer glove box, which was held at the same pO2
as the incubator. The columns were then solubilized in the lysis
buffer by using a Dounce homogenizer. The protein concentration
of each extract was determined by using the method of Bradford et
l. (1976). Equal amounts of protein (50 mg) were separated by
DS–PAGE and transferred to nitrocellulose. The antibodies used
or staining were also used to quantify protein (pVHL, fibronectin,
IF1a, and HIF2a) expression by immunoblotting as previously
escribed (Genbacev et al., 1997). Antibody binding was detected
y using species-specific secondary antibodies conjugated to horse-
adish peroxidase. Equal loading of protein was also confirmed by
mmunoblot analysis of a duplicate transfer with a monoclonal
ntibody that specifically reacts with the human cytotrophoblast
lass I molecule HLA-G (Janatpour et al., 2000). Previously, we
howed that oxygen tension does not regulate expression of this
olecule (Genbacev et al., 1997). We also used two other methods
o verify equal loading of protein: immunoblotting with anti-QM
Santa Cruz Biotechnology, Santa Cruz, CA), a stable nuclear
rotein (Dimri et al., 1996), and staining of the blots with a 10%
v/v) Ponceau S solution (2% Ponceau S in 30% trichloroacetic
cid/30% sulfosalicylic acid; Sigma Chemical Co.) dissolved in
istilled water to visualize the protein bands.
RESULTS
pVHL Expression Is Downregulated as
Cytotrophoblasts Invade the Uterus in Situ
Initially, we examined pVHL expression in tissue sec-
tions of the human maternal–fetal interface. Figure 1 shows
the major histological features of this interface before and
s of reproduction in any form reserved.
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530 Genbacev et al.after blood flow to the intervillous space is established. The
two classes of chorionic villi, floating and anchoring, share
many of the same histological features. Both have mesen-
chymal villus cores that contain fetal blood vessels, sur-
rounded by a layer of cytotrophoblast stem cells, which fuse
to form the syncytiotrophoblasts that cover the villus
surface. However, only anchoring villi form specialized
structures termed columns, aggregates of mononuclear cy-
totrophoblasts that bridge the gap between the maternal
and fetal compartments by attaching to, then invading, the
uterus. Initially, invasion is largely interstitial (i.e., through
the uterine parenchyma; Fig. 1a). Therefore, the early stages
of placental development take place in an environment that
is hypoxic relative to the uterus. As invasion continues,
cytotrophoblasts breach and colonize veins and arteries.
The endovascular component of invasion diverts the flow of
uterine blood to the intervillous space (Fig. 1b). This process
is recapitulated as the placenta grows in a radial pattern
from the site of implantation.
We examined pVHL expression by cells of the chorionic
villi both before (#10–12 weeks of gestation; late first
trimester) and after ($10–12 weeks of gestation; early
second trimester) maternal blood flow to the intervillous
space is established. At 6–8 weeks of gestation, the cyto-
plasm and periplasma membrane region of many of the
villous cytotrophoblast stem cells, in both floating and
anchoring villi, reacted with an antibody to pVHL (Fig. 2a
and inset). This pattern was observed in all eight samples
that were analyzed. At this stage of placental development,
cell columns are elongated structures containing hundreds
of cytotrophoblasts. The most intense pVHL staining was
usually (6/8 samples) observed at sites of column initiation
(tip of arrow tail) and in the proximal column region; the
intensity greatly diminished distally (arrowhead). In two
specimens, approximately half of the anchoring villi
showed staining for pVHL throughout the column. At 16
weeks of gestation, pVHL staining of some stem cells was
still observed (Fig. 2b). At this stage, cell columns are
reduced to a few rows of cytotrophoblasts. Nevertheless,
the most prominent staining was once again associated
with cytotrophoblasts in the columns that now lay imme-
diately adjacent to the uterine wall. Within the uterus,
invasive cytotrophoblasts either failed to react with anti-
pVHL or showed staining localized in a striking punctate
pattern (Fig. 2b; white arrowhead). This staining pattern
was observed in all six second-trimester samples (16–18
weeks of gestation) that were analyzed.
HIF2a Localizes to the Nucleus as
ytotrophoblasts Invade the Uterus in Situ
We also examined cytotrophoblast expression of three
proteins that interact with pVHL: fibronectin; HIF1a,
which is widely expressed (Semenza, 1999); and HIF2a,
which is primarily expressed in endothelial cells (Tian et
al., 1997). The tissue sections (late first and early second
trimester) were from the same regions of the maternal–fetal
Copyright © 2001 by Academic Press. All rightnterface as those in which pVHL expression was assessed.
s we previously reported, staining with an antibody that
ecognizes most forms of fibronectin was absent in the first
ew layers of the cell column, then upregulated distally in
oth first-trimester (Fig. 2c) and early-second-trimester (Fig.
d) anchoring villi. Antibody reactivity continued to be
etected in all parts of the column and in association with
nvasive cytotrophoblasts (Damsky et al., 1992). Only low
evels of HIF1a staining were detected in a few cytotropho-
lasts, and the pattern did not change during
ifferentiation/invasion (data not shown). In accord with
heir vascular nature (Damsky and Fisher, 1998), cytotro-
hoblasts consistently stained for HIF2a. At 7 weeks of
gestation, villous cytotrophoblast stem cells, cytotropho-
blasts at sites of column initiation, and those in the
proximal column showed relatively weak antibody reactiv-
ity that was primarily localized to the cytoplasm and
periplasma membrane region of the cells (Fig. 2e, inset).
Comparatively intense nuclear staining was first observed
in association with cytotrophoblasts in the distal region of
some columns (Fig. 2f), and the majority of cytotrophoblasts
that invaded the uterine wall, in both first-trimester (data
not shown) and early-second-trimester samples (Fig. 2f).
Hypoxia Upregulated Cytotrophoblast pVHL,
Fibronectin, and HIF2a Expression in Vitro
Next, we investigated whether the immunolocalization
patterns we observed were related to oxygen tension. Early
gestation anchoring villi and the attached proximal regions
of cytotrophoblast columns were cultured for 48 h in either
hypoxia (2% O2), 10% O2, or under standard conditions
20% O2). Hypoxia mimicked conditions in the intervillous
pace; 10% O2 was comparable to O2 levels within the
ecidua (Rodesch et al., 1992), and 20% is commonly used
or tissue culture. Under standard conditions, cytotropho-
last staining for pVHL was either weak (primarily associ-
ted with villous cytotrophoblast stem cells, cytotropho-
lasts at sites of column initiation, and a few cells in the
illus core; 4/10 placentas analyzed) or lost altogether in the
olumns (Fig. 3a; 6/10 placentas analyzed). The same re-
ults were observed when the cells were cultured in 10% O2
(data not shown). In contrast, cytotrophoblasts maintained
in hypoxia stained brightly with anti-pVHL in a pattern that
was very similar to that observed in situ (Fig. 3b). The
strongest antibody reactivity was detected in association
with cells in the proximal column region; patches of in-
tense staining were seen throughout the rest of the column.
This response was observed in anchoring villi from 8 of the
10 individual placentas that were analyzed.
We also examined the effects of oxygen tension on
cytotrophoblast expression of fibronectin, HIF1a, and
HIF2a in the same culture model. Fibronectin staining was
reatly increased in hypoxia [compare Figs. 3c (20% O2) and
3d (2% O2)]. In the latter case immunoreactivity against
human fibronectin was also detected in association with
the Matrigel substrate, which was isolated from the murine
s of reproduction in any form reserved.
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wFIG. 2. Cytotrophoblasts at the maternal–fetal interface modulate staining intensity for pVHL, fibronectin, and HIF 2a. (a) Immunostain-
ng of tissue sections of human placenta that contain anchoring villi (AV; 7 weeks of gestation) shows pVHL expression in the periplasma
embrane region and cytoplasm of a subpopulation of CTBs. Villous cytotrophoblast stem cells (vCTBs) reacted with the antibody (inset),
ut the strongest staining was always detected in the proximal cell column region (CC, tip of arrow tail), diminishing distally (CC,
rrowhead). (b) At 16 weeks of gestation, maximal staining for pVHL was again detected at sites of column initiation. Once the cells invaded
eyond the uterine (UT) surface, they either failed to react with the antibody or showed localized bright staining in a punctate pattern
white arrowhead). (c) Immunostaining of tissue sections of human placenta at 7 weeks of gestation showed that CTBs in the proximal
egions of cell columns did not react with anti-fibronectin, but strong staining was detected distally and in association with the villus core
VC). (d) Essentially the same anti-fibronectin staining pattern was observed at 16 weeks of gestation. (e) Immunostaining of a tissue section
f an anchoring villus (7 weeks of gestation) shows that strong nuclear HIF2a expression was first detected in association with
ytotrophoblasts in the distal regions of some columns. Stem cells and cytotrophoblasts in the proximal column showed a pattern of
elatively weaker, periplasma membrane and cytoplasmic staining (inset). (f) At 16 weeks of gestation, cytotrophoblasts within the uterine
all stained for HIF2a in a nuclear pattern, even when the cells were in close proximity to uterine blood vessels (UTBV). cCTB, column
cytotrophoblasts; STB, syncytiotrophoblasts; iCTB, invasive cytotrophoblasts; N, nucleus.
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5FIG. 3. Tissue section of explanted human placental anchoring villi (7 weeks of gestation) maintained in a hypoxic environment showed
enhanced staining for pVHL, fibronectin, and HIF2a. (a) Control explanted anchoring villi (AV) maintained for 48 h under standard tissue
culture conditions (20% O2) showed little anti-pVHL reactivity. Low levels of staining were detected in association with villous
ytotrophoblast stem cells (vCTB) and at sites of cell column (CC) initiation (tip of arrow tail). (b) Experimental explanted anchoring villi
aintained for 48 h in a hypoxic environment (2% O2) showed prominent staining for pVHL, particularly in the proximal column region.
ote also that anchoring villi cultured under hypoxic conditions had much larger cell columns (compare a and b, which are at different
agnifications), resulting from the substantial increase in CTB mitosis that occurs in low oxygen, as we previously reported. (c) Tissue
ections of control explanted anchoring villi showed anti-fibronectin (FN) immunoreactivity primarily in the villus cores and cell columns.
d) In hypoxia (2% O2), cytotrophoblast staining for FN increased in all compartments. Immunoreactivity against human FN was also
detected in association with Matrigel, a product of the murine Englebreth–Holm–Swarm sarcoma tumor. Staining was confined to the area
surrounding the region where cell columns attached to the extracellular matrix substrate, suggesting FN release into the matrix (marked
with an asterisk). (e) Under standard tissue culture conditions, staining for HIF2a was detected in a cytoplasmic pattern, primarily in
association with villous cytotrophoblast stem cells. The cells in columns either stained very weakly or failed to react with the antibody.
(f) In hypoxia, cytotrophoblasts in all the compartments showed enhanced HIF2a immunoreactivity that was primarily cytoplasmic. cCTB,
olumn cytotrophoblasts; STB, syncytiotrophoblasts; VC, villus core.
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533VHL Expression in Human CytotrophoblastsEnglebreth–Holm–Swarm sarcoma tumor, an observation
that suggests fibronectin secretion is enhanced in hypoxia.
The equivalent area in Fig. 3c, adjacent to the column,
showed no immunoreactivity. Again, little reactivity with
anti-HIF1a was observed (data not shown). This is in
contrast to a recent report that hypoxia upregulates HIF1a
expression in early-gestation cytotrophoblasts (Caniggia et
l., 2000). In 20% O2 villous cytotrophoblast stem cells
howed the only areas of HIF2a staining, which was largely
onfined to the periplasma membrane/cytoplasmic regions
f the cells (Fig. 3e). Staining of the cell columns was either
ery weak or absent. In hypoxia, however, stem cells and
ytotrophoblasts throughout most of the column stained in
periplasma membrane/cytoplasmic pattern (Fig. 3f).
Finally, we used immunoblotting to make a more quan-
itative assessment of the effects of oxygen tension on
ytotrophoblast expression of pVHL, fibronectin, and HIFs.
n accord with the results in which we stained sections of
issue explants, hypoxia increased pVHL expression by
ourfold (Fig. 4a), and fibronectin levels by twofold (Fig. 4b).
mmunoprecipitation of cytotrophoblast cell extracts with
nti-fibronectin, followed by SDS–PAGE separation of the
omplex and immunoblotting with anti-pVHL, showed that
he fraction of pVHL that associated with fibronectin also
ncreased by about fivefold in hypoxia (data not shown). By
he end of the experiment (48 h), HIF1a levels were the
ame in cells cultured under hypoxic and control conditions
Fig. 4c), whereas HIF2a expression dramatically increased
n hypoxia (Fig. 4d). We used several methods to ensure that
qual amounts of protein were loaded, including immuno-
lotting different regions of the same blots with antibodies
hat recognize proteins whose abundance is not regulated
y oxygen tension [QM (Dimri et al., 1996; Figs. 4e and 4f)
and HLA-G (Genbacev et al., 1997; data not shown)]. We
also stained the immunoblots with Ponceau S to visualize
the protein bands (data not shown). The same results were
obtained in experiments that analyzed the response of
anchoring villi from three individual placentas.
DISCUSSION
Our results suggest a molecular basis for the unusual way
that cytotrophoblast differentiation and invasion are regu-
lated by oxygen tension. In situ, pVHL expression was
ighest at sites of column initiation and throughout the
djacent portions of columns. In this location cytotropho-
lasts enter the cell cycle and begin to execute a complex
ifferentiation program in which they switch the expres-
ion of a broad range of stage-specific antigens. We previ-
usly showed that hypoxia in vitro replicates several inter-
esting aspects of the phenotype of cells in the proximal
column region in situ (Genbacev et al., 1997). Here we show
that under the same conditions (2% O2), cultured cytotro-
phoblasts also upregulate pVHL expression, linking this
tumor suppressor protein, which interacts with HIFs, to
this phenomenon. a
Copyright © 2001 by Academic Press. All rightThis is the first example of oxygen-dependent changes in
VHL abundance. Although we do not as yet fully under-
tand our results at a molecular level, our data suggest
everal interesting possibilities with regard to pVHL ac-
ions. For example, our finding that pVHL levels fall in the
resence of oxygen suggests that, in cytotrophoblasts,
VHL could regulate its own destruction. Whether oxygen
r other physiologic stimuli regulate the abundance of
VHL in other tissues remains to be determined. Although
his relationship has not been observed in tumor cell lines
FIG. 4. Immunoblotting confirms that hypoxia in vitro signifi-
antly increases pVHL, FN, and HIF2a expression in cytotropho-
blast columns of anchoring villi. Different regions of the same blot
were analyzed using one of five antibodies. (a) Scanning densitom-
etry showed cell columns of explants cultured for 48 h in 2% O2
contained four times more pVHL than did those of villi maintained
under standard culture conditions (20% O2) for the same length of
ime. (b) Under the same conditions, expression of FN increased
wofold in 2% O2 as compared to that in 20% O2. (c) Expression of
IF1a was not influenced by oxygen tension. (d) HIF2a expression,
hich was barely detectable in cell columns of control anchoring
illi, was dramatically induced by hypoxia. (e and f) Immunoblot-
ing with an antibody that specifically reacted with QM, a protein
hose expression is not regulated by oxygen tension, showed that
qual amounts of protein were loaded from lysates of cells that were
ultured in either 20 or 2% O2. Control (e) was for the blots shown in
a and c, and control (f) was for the blots shown in b and d.dapted for growth in 20% O2, it is possible that other
s of reproduction in any form reserved.
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534 Genbacev et al.primary cells might show a response similar to that of
cytotrophoblasts. Whatever the mechanism, the downregu-
lation of pVHL during cytotrophoblast differentiation likely
contributes to uterine invasion through upregulation of
MMP-9 and decreased fibronectin matrix assembly.
In hypoxia in vitro, HIF2a and pVHL levels rose concur-
ently. Our immunolocalization data show that when high
evels of pVHL and HIF2a are expressed in the same cell,
the two proteins colocalize outside the nucleus. Although
pVHL is presumably inactive as an E3 ubiquitin ligase that
targets HIF for degradation under these conditions, it may
nonetheless sequester this transcription factor in the cyto-
plasm and thus still inhibit hypoxia-inducible gene expres-
sion. Preliminary data support such a view (W. Kaelin,
unpublished results). For example, neither maternal nor
fetal vessels cross the maternal–fetal interface, suggesting a
relative absence of angiogenic factors in this area. Finally,
immunolocalization studies in situ showed that as pVHL
expression declined in parallel with uterine invasion, HIF2a
staining localized to the nucleus. In the context of the
oxygen gradient at the maternal–fetal interface (Fig. 1), this
observation suggests that relatively lower levels of oxygen
are required to upregulate pVHL than to upregulate HIF2a
expression. As to the consequences, we hypothesize that
HIF2a-induced gene expression may regulate aspects of the
seudovasculogenesis differentiation program that invasive
ytotrophoblasts execute within the uterine wall.
Accordingly, pVHL and HIF2a expression may be key
elements of placental development. With regard to pVHL,
expression of this tumor-suppressor protein may be an
integral part of the mechanism that maintains an adequate
population of cytotrophoblast stem cells, akin to the func-
tion of Mash-2 in murine placental development (Guil-
lemot et al., 1994). This would explain why VHL2/2 mice
ie at midgestation from placental defects that include
bnormal trophoblast differentiation and placental vascu-
arization (Gnarra et al., 1997). Likewise, our data also show
hat when pVHL expression is downregulated, HIF2a is
etected in the nucleus. This finding links the transcrip-
ional activity of the latter molecule to a role in trophoblast
ifferentiation and may explain why mice that do not
xpress the HIF heterodimerization partner ARNT have a
henotype that is similar to that of the VHL2/2 animals
(Kozak et al., 1997; Adelman et al., 2000). Generation of
VHL2/2 and ARNT2/2 mice with wild-type placentas (by
etraploid rescue) will show whether this phenomenon is
imited to the extraembryonic membranes or occurs during
he development of other tissues and organs. Our finding
hat cytotrophoblasts express both HIF1a and HIF2a raises
he possibility of compensation and could explain why
omozygous null deletions in either gene produce mouse
mbryos with primarily intraembryonic defects (Iyer et al.,
998; Ryan et al., 1998; Tian et al., 1998).
Conversely, loss of pVHL expression, which occurred in
itu as cytotrophoblasts moved into the distal column
egion and invaded the uterine wall, may be an equally
mportant part of the trophoblast differentiation program.
C
Copyright © 2001 by Academic Press. All rightn tumor cells, homozygous VHL mutations that impair the
unction of the protein form lead to oxygen-independent
xpression of HIFs and HIF-regulated gene products, includ-
ng vascular endothelial growth factor and glucose
ransporter-1, events that are thought to be critical steps in
umorigenesis. In situ, cytotrophoblasts that lose pVHL
xpression acquire invasive properties that allow them to
raverse much of the uterine wall (Librach et al., 1991),
ssume a vascular phenotype (Damsky and Fisher, 1998),
nd synthesize and break down large quantities of glycogen
Genbacev et al., 1993; Enders, 1997). In vitro, cytotropho-
lasts spontaneously downregulate pVHL expression and
xecute this differentiation program when they are cultured
n an O2 atmosphere of either 10 or 20% (Librach et al.,
991; Damsky et al., 1994; Genbacev et al., 1997). Together,
our data suggest that loss of pVHL expression, which is
regulated by oxygen tension, is another important step in an
autocrine differentiation process that gives rise to a sub-
population of cytotrophoblasts with a phenotype often
associated with tumor cells, providing molecular evidence
for the long-held opinion that placental development en-
tails important aspects of tumorigenesis.
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